The University of Southern Mississippi

The Aquila Digital Community
Honors Theses

Honors College

Fall 12-2016

Teenagers Need Drugs Too: Attitudes on the Accessibility and
Acceptability of the HPV Vaccine from Parents of Different
Socioeconomic Statuses
Kristen Angell' Dupard
University of Southern Mississippi

Follow this and additional works at: https://aquila.usm.edu/honors_theses
Part of the Community Health and Preventive Medicine Commons

Recommended Citation
Dupard, Kristen Angell', "Teenagers Need Drugs Too: Attitudes on the Accessibility and Acceptability of
the HPV Vaccine from Parents of Different Socioeconomic Statuses" (2016). Honors Theses. 439.
https://aquila.usm.edu/honors_theses/439

This Honors College Thesis is brought to you for free and open access by the Honors College at The Aquila Digital
Community. It has been accepted for inclusion in Honors Theses by an authorized administrator of The Aquila
Digital Community. For more information, please contact Joshua.Cromwell@usm.edu.

The University of Southern Mississippi

Teenagers Need Drugs Too: Attitudes on the Accessibility and Acceptability of the HPV
Vaccine from Parents of Different Socioeconomic Statuses

by

Kristen Angell’ Dupard

A Thesis
Submitted to the Honors College of
The University of Southern Mississippi
in Partial Fulfillment
of the Requirements for the Degree of
Bachelor of Science
in the Department of Chemistry and Biochemistry

December 2016

i

ii

Approved by

_______________________________
Ray G. Newman, Ph.D., Thesis
Adviser
Professor of Public Health

_______________________________
Ray G. Newman, Ph.D., Chair
Department of Public Health

_______________________________
Ellen Weinauer, Ph.D., Dean
Honors College

iii

Abstract

Cervical cancer is one of the leading causes of death among women around the
world and is linked to the human papillomavirus (HPV). Strains HPV-16 and-18 are
linked to the causes of cervical cancer. Research shows that HPV vaccination in
adolescent females projects a 70% non-contraction rate. However, only 57.3% of girls
between the ages of 13-17 in the U.S. have received their first HPV vaccination dose.
Researchers have begun speculating that factors such SES and race could be contributing
to low vaccination participation. Answers to such information can aid in improving
federal and state vaccination policies and prevent the diseases caused by HPV. The
current study aimed to determine if race and socioeconomic status (SES) interacted in
such a way that predicted the attitudes of minority caregivers toward the HPV vaccine in
terms of its acceptability and accessibility. Parents of adolescent females enrolled at a
local Mississippi high school were surveyed to determine if this interaction predicts lower
vaccination rates. It was anticipated that minority parents of low SES would have lower
vaccination rates than those of higher SES. The univariate results indicated the
following: 90% of participants identified as African American/Black, 39% (majority) of
the respondents had completed some college or obtained an associate’s degree, 42%
(majority) of the income level was between $30,001-$50,000, and 70% of daughters had
received some shots of the HPV vaccination. Bivariate Chi-Square (𝑋 2 ) analyses
determined if categorical independent variables (Race, Education, and Finances) were
significantly associated with vaccine participation. Bivariate tests were not statistically
significant (p> 0.05). However, a correlation between vaccination participation and
income showed that the higher the income level, the more likely a parent was to vaccinate
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their daughter against HPV. Other independent variables yielded significance. At the
univariate level, 74% of health care providers had recommended the vaccine, 72% of
respondents had insurance to cover vaccine, and 70% of respondents had very easy
access to health care. At the bivariate level, only two independent variables were
significant. The results showed the following: insurance coverage: (95 % CI: (1.03820.3810) (𝑋 2 = 4.353, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.037) and vaccine recommendation (95%
CI: 3.675-156.738) (𝑋 2 = 14.727, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.0001). Being recommended
by a health care provider was a significant predictor of vaccine participation at the
multivariate level. Ostensibly, parents are aware of the vaccine and are taking preventive
measures. Additional research could answer whether minority caregivers from low SES
will be less inclined to have their adolescent daughters vaccinated. HPV is one of the
most preventive, yet deadly, STIs and further research is imperative.

Keywords: HPV, vaccine, cervical cancer, race, socioeconomic status
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Chapter 1: Introduction
Cervical cancer is one of the leading causes of death among women around the
world that is caused primarily from sexual contact. The human papillomavirus (HPV) is
a sexually transmitted virus that at least half of sexually active men and women will
contract. Strains HPV-16 and-18 are linked to the causes of cervical cancer that are
responsible for 4,000 annual fatalities. Recent studies suggest that HPV vaccination in
adolescent females between the ages of 9-16 (before sexual activity initiation), projects a
70% non-contraction rate. However, only 57.3% of girls between the ages of 13-17 in
the United States have received the first HPV vaccination dose.
Researchers speculate that outside factors such as class and race contribute to low
participation in HPV vaccination. Class and race play vital roles in the vaccination of
young female adults because of increasing health care costs. To further investigate these
findings, parents/guardians of high school adolescent females from the Hattiesburg area
completed a Likert scale survey. The purpose of this study was to determine how race
and socioeconomics status (SES) interact in such a way that minority parents with low
SES are more apprehensive about giving their adolescent daughters vaccine due to the
lack of health education and physician accessibility. Results were assembled and
analyzed appropriately.
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Chapter 2: Literature Review
In 1956, a group of researchers from several countries discovered human
papillomavirus (HPV) ( Roxas). Little is known about the initial discovery and the
researchers responsible. However, in 1972, female Polish dermatologist Stefania
Ginsburg-Jabłońska discovered the link between skin cancer and HPV (Kibbe, 2012). It
was not until the 1980s that HPV DNA was found in genital lesions and HPV-16 and -18
were extracted from the cervix by German virologist Harald zur Hausen (Aronowitz,
Epstein, Livingston, & Wailoo, 2010). zur Hausen went on to win the Nobel Peace Prize
in Medicine in 2008 for his 1976 research and is credited with discovering the link
between HPV and cervical cancer (Aronowitz, Epstein, Livingston, & Wailoo, 2010).
HPV is a sexually transmitted virus infection (STI) that currently affects 20
million people in the United States (The Centers for Disease Control and Prevention,
2012). At least 50% of all sexually active males and females will contract HPV at some
point in their lifetimes (Food and Drug Administration Office of Women’s Health, 2015).
By definition, these viruses are known as papilloma because they have the ability to
cause genital warts or benign tumors (American Cancer Society, 2014). These papilloma
viruses reside in epithelial cells (cells that are located on the skin and moist surfaces of
the body) that can be found on surfaces of the vagina, anus, cervix, trachea, eyelids, and
other moist parts of the body (American Cancer Society, 2014). Unlike human
immunodeficiency virus (HIV), which is an infection found in the bodily fluids of an
infected person, HPV is a virus that affects the skin and moist membrane linings. Humans
are susceptible to HPV contraction through vaginal, anal, and or oral sexual contact with

2

an infectious person. HPV has no cure, but there are vaccines that can prevent the viral
infection (The Centers for Disease Control and Prevention, 2011).
According to the Centers for Disease Control and Prevention (2013), 110 million
people in the U.S. are infected with an STI and approximately 20 million new infections
surface yearly that cost $16 billion in national medical expenditures. A 2013 report
released by the CDC states “that HPV accounts for the majority of newly acquired STIs”
(The Centers for Disease Control and Prevention, 2013). The CDC estimates that HPV
cases make up 14,100,000 (90%) new STI cases in the U.S. and young people between
the ages of 15-24 make up half of those incident cases (The Centers for Disease Control
and Prevention, 2013).
Unlike STIs such as gonorrhea, HPV is asymptomatic. Thus, thousands of cases
go undiagnosed annually. The National Cancer Institute (2012) suggests that 42.5 percent
of women have genital HPV infections, whereas fewer than 7% of adults have oral HPV
infections at any point in time. Contraction of HPV increases if sexual activity begins at
an early age or if a young person (ages between 9-26) has polygamous sexual
relationships (The National Cancer Institute, 2012). Besides sexual skin contact, the odds
of HPV contraction increase if one smokes, has HIV or any other immune system
deficiency, uses birth-control for more than five years, or has three or more children
(Food and Drug Administration Office of Women's Health , 2015). Most HPV strains
resolve without intervention, while others cause genital warts, which present as soft
growths on the skin and mucus membranes of the genitals. With over 150 strains of HPV,
only types 16 and 18 are known to be carcinogenic (American Cancer Society, 2014).
Strains 16 and 18 have been of significant interest because they are linked to cervical
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cancer, which is one of the most fatal cancers among women in the United States
(American Cancer Society, 2014).
In order to understand the link between cervical cancer and HPV, the origin and
areas affected by cervical cancer must be thoroughly explained. Cancer is a disease in
which cells divide abnormally. Regions in which those cells grow irregularly are given
names based on their bodily location. Cervical cancer is a disease that originates within
the cervix of a female. The cervix connects the vagina to the uterus in the female organ
system. Cervical cancer is caused from HPV strains 16 and 18 (The Centers for Disease
Control and Prevention, 2012). Detection of this disease comes from annually scheduled
Papanicolaou smear tests (Pap Test) that identify cancerous cells on the cervix, or HPV
tests which detect the virus itself. Early signs and symptoms are rare but they can include
abnormal or bleeding discharge from the vagina (The Centers for Disease Control and
Prevention, 2012). If HPV is contracted, cervical cancer can take 10-20 months to fully
develop. As the third leading type of cancer among women in the United States,
approximately 12,000 cases are diagnosed each year (American Cancer Society, 2014).
The American Cancer Society (2014) suggests that in 2015, 4,100 women will die from
cervical cancer. Eighty-five percent of the women diagnosed with cervical cancer will be
younger than 65, with Blacks and Hispanics having higher rates (American Cancer
Society, 2015).
As previously stated, in 1976 Harald zur Hausen discovered the link between
cervical cancer and HPV. However, it was not until June of 2006 that the Food and Drug
Administration (FDA) approved Merck & Co., Inc.’s distribution of the Gardasil Human
Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant to prevent
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infection with the two most commonly occurring strains of HPV that cause cervical
cancer and the two most commonly occurring strains of HPV that cause genital warts.
(Aronowitz, Epstein, Livingston, & Wailoo, 2010). According to the National Institutes
of Health, the FDA has approved Gardasil for use in females for the prevention of
cervical cancer and some vulvar and vaginal cancers caused by HPV types 16 and 18, and
for use in males and females for the prevention of anal cancer and precancerous anal
lesions caused by HPV types 16 and 18 (The National Cancer Institute, 2012). Gardasil is
one of two vaccines known to prevent strains 6, 11, 16, and 18. The other vaccine is
GlaxoSmithKline's Cervarix, and it is only known to prevent HPV strains 16 and 18.
Gardasil is injected into muscle tissue in a series of three doses over a six-month period.
It is highly recommended by physicians and health agencies for adolescents (male and
female) before they become sexually active. This vaccine is recommended for nonpregnant women between the ages of 9-26.
Since becoming available in 2006, an estimated 70% of cervical cancer cases
among those who received the complete vaccination series were prevented (The Centers
for Disease Control and Prevention, 2011). The earlier a young person receives the
vaccination, the less susceptible he or she is to contract the viral strains linked to cervical
cancer. However, while Merck’s Gardasil vaccine made strides with regard to cancer
prevention and STI treatment, its cost sparked controversy. At $350 per dose in 2007,
Merck & Co., Inc. had the monopoly on the Gardasil vaccine because they were the only
company distributing it (Aronowitz, Epstein, Livingston, & Wailoo, 2010). Thus, they
had almost complete control over the cost and distribution. Costs for Gardasil in 2006,
which at this point had become known as a preventive “cancer drug,” drew closer
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attention to the United States’ “haves and have-nots” (Aronowitz, Epstein, Livingston, &
Wailoo, 2010). In other words, the cost of this vaccine illuminated economic disparities
between those who could and could not afford it.
In April of 2014, the American Cancer Society estimated that the price of
Gardasil ranged from $130 to $140 per dose with the total cost being $360 not including
the cost of the physician visit (American Cancer Society, 2014). This was a significant
reduction from the $350 per dose cost that was charged before the 2010 Patient
Protection and Affordable Care Act (PPACA or Affordable Health Care Act), which
mandated that “plans and issuers are required to provide coverage without cost-sharing
for this service exactly” (U.S. Department of Health & Human Services, 2012). This
means that health and insurance companies cannot share the cost of the vaccine but must
choose whether or not to pay for health fees. Although costs of the vaccination series
have been reduced since 2006, currently the cost is $360 per vaccination series per person
(American Cancer Society, 2014).
It is important to consider this issue of cost from a socioeconomic standpoint. The
American Psychological Association defines socioeconomic status (SES) as the
following:
Socioeconomic status (SES) is often measured as a combination of education,
income, and occupation. It is commonly conceptualized as the social standing or
class of an individual or group. When viewed through a social class lens,
privilege, power, and control are emphasized. Furthermore, an examination of
SES as a gradient or continuous variable reveals inequities in access to and
distribution of resources (American Psychological Association, 2015).
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The U.S. Census Bureau stated that in 2012 the average income family earnings
(family of four) based on socioeconomic class were as follows: lower class at $23,050,
lower middle class between $32,500 and $60,000, upper middle class at $100,000, and
the upper class at $250,000 (Francis, 2012), The average American family of four in
2014 spent $23,215 on healthcare with an average employer sponsored health plan
(Milliman, 2014). Costs more than doubled in 2014 over 2004 when the average family
spent just $11,192 (Milliman, 2014). With the median household income at $51, 939,
almost half of the average American family’s earnings is spent on healthcare for families
with average insurance plans (Milliman, 2014). This income ratio as it relates to SES
limits health care access to certain groups that fall within the lower and middle class
income levels. Ostensibly, over the past 50 years, medicine’s ability to increase the
quality of life and life expectancy has illustrated the gap between those who do and do
not have access to health care in the United States (Swartz, 2009).
It is evident that the relationship between income and healthcare cost for average
Americans is non-proportional and that this ratio is the result of health disparities among
specific groups such as minorities. The Centers for Disease Control (2014) defines
minorities as Asian American, Black or African American, Hispanic or Latino, Native
Hawaiian and Other Pacific Islander, American Indian and Alaska Native. In 2013, the
average income of minorities was $33,901 (DeNavas-Walt & Proctor, 2014). In that same
year, the income level among Whites was $55,257 (DeNavas-Walt & Proctor, 2014).
Average minorities fall into the lower class and lower middle class based on their
earnings. Because of this, average minority households do not have easy access to
healthcare, primarily because they cannot afford it. For example, a study published by the
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United States Bureau of Labor Statistics (2014) analyzed the average income of African
American households, and found that the average income in an African American
household was $45,287. Of that income, $1,794 was spent on healthcare (Noël, 2014). It
is plausible to infer that the low income of average minorities affect how much they
spend on healthcare. On average, minorities fall into a socioeconomically deprived class
that cannot afford healthcare. As a domino effect, this situation deprives minorities of
health education, which is part of the reason they do not receive vaccinations.
In order to fully understand how SES impacted the accessibility of the Gardasil
vaccine to minority groups, it is necessary to examine what began to transpire in the
United States economically at the time of Gardasil’s initial distribution and how that
relates to socioeconomic disparities. The National Bureau of Economic Research stated
that in December of 2007, the United States along with other countries around the world
began to experience the Great Recession. This led to the loss of 8.9 million jobs across
the country between 2007 and 2010. Minorities were among those most affected by this
recession. Pew’s Research Center reports:
From 2005 to 2009, inflation-adjusted median wealth fell by 66% among
Hispanic households and 53% among black households, compared with just 16%
among white households. As a result of these declines, the typical black
household had just $5,677 in wealth (assets minus debts) in 2009; the typical
Hispanic household had $6,325 in wealth; and the typical white household had
$113,149. Worse, 35% of African Americans and 31% of Hispanics reported zero
or negative net worth in 2009. By contrast, only 15% of white households were in
the same boat (Taylor, Kochhar, Fry, Velasco, & Motel, 2011).
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Because of the loss of jobs and the net worth among minorities during this great
recession, many lost access to affordable health insurance. Access to health services
diminished and the consideration of risking savings on a new expensive vaccine was
unlikely. The 16% of white households that were affected, compared to the 66% of
African Americans and 53% of Hispanic households that were affected, illustrates who
was excluded from Merck’s vaccine during its initial distribution stages due to cost. Nonminority groups had better access to health care services because only a small percentage
of their household populations was affected. Thus, they were more likely to receive the
vaccination because they could afford it. Because of this monopoly and the country’s
economic crisis, some minorities of low socioeconomic status were financially excluded
from obtaining Gardasil.
Attempts to indirectly remedy the problem of Gardasil’s cost only furthered the
problem for these minority groups. In late 2006, 26 state legislatures across the United
States began to produce legislation that required the vaccine to be received by middle
school girls (Aronowitz, Epstein, Livingston, & Wailoo, 2010). Of these 26 states, 22
state legislative bodies rejected the Gardasil mandate (Aronowitz, Epstein, Livingston, &
Wailoo, 2010). Many legislators, conservative organizations, and concerned
parents/guardians viewed the Gardasil mandate as healthcare socialism while some
viewed it as a positive governmental intervention that benefited the health of its citizens.
Only the District of Columbia and Virginia passed legislation mandating the vaccine.
Despite the fact that Texas rejected these mandates, Texas Governor Rick Perry went as
far as issuing an executive order to mandate the vaccine (Aronowitz, Epstein, Livingston,

9

& Wailoo, 2010). Perry’s use of governmental authority was overruled and no laws were
implemented.
In the midst of these proposed mandates, the question of cost began to surface,
including who would cover the cost and what type of economic burden this would place
on the average American family. In 2013 (eight years since the beginning of these
mandates), only eight states provided funding for this vaccine (The Henry J. Kaiser
Family Foundation, 2013). This left the other 42 states’ citizens to rely upon federal,
private, and employment based insurance to compensate for the cost. This burden of cost
continues to increase for average lower and working class citizens, especially when
health insurance companies opt out of covering the vaccine’s cost.
This problem of cost is most prevalent among those who are socioeconomically
disadvantaged. In this way, HPV vaccination can be viewed as both a health care issue
and a socioeconomic problem that targets specific social classes in each state. The state
of Mississippi is a clear representation of the socioeconomic disparity attached to HPV
vaccination. The issues that Mississippi faces regarding HPV vaccination revolve around
the fact that HPV vaccination is not accepted by or accessible to those with low SES and
minority racial groups.
Mississippi is composed of 59.8% Whites, 37.4% of Blacks/African Americans,
and 2.8% Asian, Hispanic or Latino Americans (U.S. Census Bureau, 2014). In 2014, the
average income of Mississippians was $39,031 (U.S. Census Bureau, 2014), making it
the poorest state in America. Today, 22.7% of Mississippians are below the poverty level
in comparison to the national average of persons below poverty level, which is 15.7%
(U.S. Census Bureau, 2014). Minorities in Mississippi are the most socioeconomically
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disadvantaged group of individuals in the state. For example, the household income of
Blacks in 2006, “was $21,969 or just 51% that of white households ($43,139)” (Hill,
2008). This study on the Economic Status of Blacks in the State of Mississippi
highlighted the economic disparity between racial groups and how those who come from
a lower SES background suffer (Hill, 2008).
The majority of Mississippians from low SES backgrounds also lives in
impoverished communities. As a result they only have access to substandard education.
To understand how Mississippi’s impoverished communities affect education, it is
important to explore national correlations between poverty and education.
More than one in five U.S. children live in “official” poverty today, with an even
higher rate for Black and Hispanic children and for those in families headed by a
single parent. Among the world’s 35 richest countries, the United States holds the
distinction of ranking second highest in child poverty. A large body of research
continues to document the negative effects of poverty on children and their later
life outcomes. Children growing up in poverty complete less schooling, work and
earn less as adults, are more likely to receive public assistance, and have poorer
health (Coley & Baker, 2013).
Twenty-two percent of children in the U.S. live in poverty (National Center for Children
in Poverty (NCCP), 2014). Statistically, these national trends have placed not only a
strain on the U.S. economy, but also they continue to jeopardize the health education of
its citizens. Predictably, Mississippi’s correlations between poverty and education fall
below the national trends. Thirty-two percent of children in Mississippi live in poverty
(National Center for Children in Poverty (NCCP), 2014). Of that 32%, child minorities
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are the most impoverished. Columbia University researchers at the National Center for
Children in Poverty (2014) estimate that “49% of Blacks and 40% of Hispanics in
Mississippi are impoverished while only 17% of Whites fall into that category.” This
relates to education because the higher the average poverty rate, the less likely one is to
attend college (The Pell Institute for the Study of Opportunity in Higher Education,
2015). Overall, this decline in the ability to climb the educational ladder limits their
knowledge and access to health education because they cannot afford education let alone
healthcare. Inadequate health education and access increase in Mississippi as poverty
continues to increase. Limited health education and access to health care increases the
risk for impoverished Mississippians to develop health problems.
In 2014, Mississippi ranked last in overall health (United Health Foundation,
2014). Mississippi currently has the second highest sexually transmitted infection (STI)
rate in the U.S., including but not limited to HIV, gonorrhea, trichomoniasis, syphilis, and
HPV. Despite the fact that it ranks among the highest in incidence rates for STIs, it has
one of the lowest budgets for overall health. Furthermore, Mississippi only allocates
$1,354,661 in preventive funding (The Henry J. Kaiser Family Foundation, 2013).
In 2014 Mississippians had a 78.5% preventable hospitalization rate (United
Health Foundation, 2014). According to the United Health Foundation, immunization
among young adults (who make up half the amount of new STI/STD rates) could have
significantly decreased this hospitalization rate. Mississippi is ranked 11th in the country
for child immunization (United Health Foundation, 2014). Although 74.6% of children
ages 1-12 in Mississippi are immunized, only 45.2% of adolescents between the ages of
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13-27 are immunized (United Health Foundation, 2014) . This leaves Mississippi with an
overall state adolescent immunization ranking of 50 (United Health Foundation, 2014).

As previously noted, HPV makes up 90% of newly acquired STI infections in the
United States. HPV, like most STIs, is a preventable disease. Its contraction rate and the
amount of hospitalizations associated with HPV could be significantly decreased if
vaccination was more prevalent in Mississippi. No laws, governing policies, funding, or
mandates regarding the HPV vaccinations have been implemented in Mississippi (The
Henry J. Kaiser Family Foundation, 2015). Mississippi is one of ten states in which fewer
than 30% of adolescents (between the ages of 13-17) have received the HPV vaccination
(The Henry J. Kaiser Family Foundation, 2015).

Nationally, socioeconomic hardship has proven to be one of the primary reasons
why parents are not having their adolescent sons and daughters vaccinated against HPV.
This, along with lack of education about the vaccine, seems to play a major role in why
minority individuals from a low SES background are not having their children vaccinated
in southern Mississippi. The current study focuses on determining if race and
socioeconomic status (SES) interact in such a way that will predict the attitudes of
minority caregivers toward the HPV vaccination, in terms of its acceptability and
accessibility. It is presumed that minority caregivers in Mississippi from a low SES will
be less inclined to have their adolescent daughters vaccinated due to their lack of
education about the vaccine as well as their inability to afford the vaccine.

Parents of guardians of adolescent females enrolled at Hattiesburg High School
in Hattiesburg, Mississippi, were surveyed to determine if this interaction predicted lower
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vaccination rates. This population was chosen because HPV is responsible for cervical
cancer fatalities among women and adolescent females and because Mississippi women
have a higher cervical cancer contraction rate than the national average (Mississippi State
University, 2010). This population was also chosen because the Hattiesburg area has an
increasing STI incidence rate (Frelix, 2009). Understanding this relationship is important
because it answers questions regarding how parents in Mississippi feel about the HPV
vaccine. Such information could have implications for health policies at both the state
and federal levels that could help to improve vaccination policies and prevent the
diseases caused by HPV.
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Chapter 3: Methodology
Participants
Participants were 18 years of age or older and were the current parent/guardian of
an adolescent female at Hattiesburg High School.
Measures
A 22-item questionnaire was distributed to all parents/guardians of Hattiesburg
High School students in order to examine the extent to which race and SES influence
parental attitudes toward the HPV vaccination of adolescent females. Most questions
were answered on a 5-point Likert scale. Items were adapted from a survey used in a
study conducted by Reiter et al. (2009) regarding parental attitudes toward the HPV
vaccine.
Procedure
Before distributing the questionnaire, permission was sought from both the
superintendent’s office of the Hattiesburg Public School District and the principal of
Hattiesburg High School. Upon receiving approval, the principal of Hattiesburg High
School distributed an anonymous survey link via email to all parents/guardians of
Hattiesburg High School students. This survey was administered using the web-based
Qualtrics survey system. Responses were immediately uploaded to the Qualtrics system
and remained completely anonymous. The survey remained open for two weeks.
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Chapter 4: Results and Discussion
Experimental Results
On the first attempt, a survey was sent via email to a total of 1,053
parents/guardians at Hattiesburg High School. On the second attempt, the survey was
emailed to a total of 1,114 parents/guardians at Hattiesburg High School. A total of 60
respondents completed the survey. Only 43 of the 60 respondents answered whether their
child had received any shots of the HPV vaccination. Of those 43 participants, 90% of
them identified as Black (Figure 1). Most of the respondents had completed some college
or obtained an associate’s degree (Figure 2). The majority income level of respondents
was between $30,001-$50,000 (Figure 3). More than half of the respondents answered
“Yes” to their adolescent daughter receiving the HPV Vaccination (Figure 4) and
provided reasons why (Figure 5 and Figure 6). Once these univariate descriptive statistics
were examined, bivariate Pearson Chi-Square (𝑋 2 ) analyses were conducted to determine
if categorical independent variables were significantly associated with vaccine
participation (Table 1). The results of all hypothesis driven analyses were non-significant.
However, a general correlation was observed between income level and vaccine
participation (Table 2). Results show that the higher the income of the respondent, the
more likely parents were to vaccinate their adolescent daughters against HPV.
Exploratory Results
Some univariate results also proved to be of significance. Figure 7 shows that
74% of healthcare providers recommended the vaccine. Figure 8 shows that 94% of the
respondent’s insurance covered the vaccine. Although the hypothesized data were not
statistically significant, additional bivariate analysis produced results that were
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statistically significant (Table 1). Because of these findings, a logistic regression analysis
was conducted to model the relationship between independent and dependent variables.
Those independent variables found to be significantly associated with vaccine
participation at the bivariate level were included in the multivariate model (Table 2). The
only independent variable that remained statistically significant during the logistic
regression was the question regarding vaccine recommendation by health care providers
(95% CI: 3.675-156.738) (𝑋 2 = 14.727, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.0001) (Table 2).
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Experimental Tables and Figures

Race of Survey Respondents
(N=43)
10%
Black
White
90%

Figure1. Race of Survey Respondents

Education of Survey Respondents
(N=43)
High School
Diploma or Less

9%

26%

Some college or
associates degree
39%

BS degree

26%

Anything above
BS

Figure 2. Education of Survey Respondents
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Income of Survey Respondents
(N=43)
14%

25%

$0-$30,000
$30,001-$50,000

19%

$50,001-$80,000
$80,001 and
above

42%

Unemployed
Figure 3. Income of Survey Respondents

HPV Vaccination
(N=43)

30%
Yes
70%

Figure 4. HPV Vaccination
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No

Reasons to Vaccinate Against HPV Provided by Parents of
Adolescent Daughters
(N=43)
7%

11%

To Prevent
Cervical Cancer

82%

Daughter is at
High Risk for
Cervical Cancer
Other

Figure 5. Reasons to Vaccinate Against HPV Provided by Parents of Adolescent Daughters

Reasons Not to Vaccinate Against HPV Provided by Parents of
Adolescent Daughters
Never Heard of
(N=43)
the Vaccine
23%

Need More
info/don't know
enough about it
Vaccine too new

23%

8%
8%

23%
8%

7%

Vaccine unsafe
Daughter is too
Young

Figure 6. Reasons Not to Vaccinate Against HPV Provided by Parents of Adolescent
Daughters
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Table 1. Bivariate Results for Race, Education, and Financial (N=43)
Table 1. Bivariate Results for Race, Education, and Finances (N=43)
Independent
Variable

Category (N=43)

Percent
Chi-Square Value
Vaccinated Tests

Df

Race

Black (37)

70.30%

Education

Some College or
Associates Degree
(17)
$30,001-$50,000 (15)

64.70%

Financial

73.30%

Table 2. Bivariate Results for Income (N=43)
Has your daughter $0-$30,000 $30,001-$50,000
had any shots of
the HPV Vaccine?
Yes
4
11
No
5
4
Total
9
15
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Pearson
Chi-Square
Pearson
Chi-Square

1.612

2

Asymp.
Sig.
(2-sided)
0.447

1.751

3

0.626

Pearson
Chi-Square

6.878

5

0.230

$50,001-$80,000

$80,001- and
above

7
0
7

4
1
5

Exploratory Figures and Tables

Vaccine Recommendation
(N=43)

26%

Yes

No
74%

Figure 7: Vaccine Recommendation

Vaccine Insurance Coverage
(N=43)

28%

Yes

No
72%

Figure 8. Vaccine Insurance Coverage
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Health Care Accessibility
(N=43)

30%

Somewhat
Easy &Easy
Very Easy

70%

Figure 9. Health Care Accessibility (N=43)
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Table 3. Bivariate Results for Exploratory Analysis (* indicates significance)
Independent
Variables
HPV
Insurance
Coverage
Health Care
Access
Health Care
Recommenda
tion

Category
(N=43)
Yes (28)

Percent
Vaccinated
82.1%

Chi-Square
Tests
Pearson ChiSquare

Value

Very
Easy (28)
Yes (28)

78.6%

Pearson ChiSquare
Pearson ChiSquare

3.265

85.7%

4.353

Df Asymp. Sig
(2-sided)
0.037*
1
1
0.071*
1
1

14.72
7

0.0001*
1
1

Table 4. Multivariate Regression of Vaccine Recommendation (* indicates significance)
Step 𝟏𝒂

Df

Sig

Exp (B)

Q22 Recode:
Vaccine
Recommendation

1

0.001*

24.000

95% C.I.
Lower
3.675
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95% C.I.
Higher
156.738

Chapter 5: Conclusion

Experimental Conclusion
Examining how race and SES interact to determine how minority
parents/guardians with low income feel toward vaccinating their adolescent daughters
against HPV did not yield the expected results. The literary analysis concludes that
minority parents of low SES are more unlikely to vaccinate their children against HPV.
This lack of vaccination participation is reportedly due to a lack of educational and
financial means regarding vaccination (Coley & Baker, 2013). In the current study, the
data do not support those described in the literature pertaining to vaccination, race, and
SES. Approximately 90% of the survey respondents were Black and 70% of the
respondents’ adolescent daughters had received at least some shots of the vaccine. While
the majority of respondents had some college education but made no more than $50,000 a
year, a majority of their daughters still received some, if not all, shots of the vaccine
series. These descriptive statistics illustrate how minorities of low SES are not entirely
apathetic toward HPV vaccination. At the univariate level, these results suggest that
parents/guardians are aware of the HPV vaccine and are pursuing preventive measures to
protect their daughters. No differences between white or black, rich or poor, influenced
whether or not parents/guardians vaccinated their daughters against HPV. This finding
could be due to a small respondent pool.
At the bivariate level, the hypothesized analysis did not yield significant results.
The Pearson Chi-Square test was used to determine if there was a significant association
between vaccination participation and key categorical variables. An analysis of the
association between race and HPV participation yielded a Pearson Chi-Square test 𝑋 2 =
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1.612, 𝐷𝑓 = 2, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.447. Analysis of the association between educational
level and HPV participation yielded a Pearson Chi Square of 𝑋 2 = 1.751, 𝐷𝑓 =
3, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.626. Analysis of the association between income before taxes and HPV
participation yielded a Pearson Chi-Square of 𝑋 2 = 6.878, 𝐷𝑓 = 5, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.230.
Because no association was found (p ≤ 0.05) between any of the above variables pairs,
multivariate inferential statistics were not conducted. This lack of a significant
association showed that SES (education and finances) and race had no significant
relationship to HPV vaccination participation. This lack of significance between
vaccination participation and Race and SES could be due to the lack of a large
respondents population. Although these results yielded no significant relationships, a
correlation was noticed between income and vaccination participation (Table 2). The
percentage of respondents vaccinating their daughters rose for each increasing income
bracket. In the first category 44.4% were vaccinated, in the second income bracket 73.3%
were vaccinated and in the highest income bracket 80% were vaccinated. As income
increases, vaccination rates increase. This trend supports the findings in other studies that
suggest that the higher the income level, the more likely one is to vaccinate their daughter
against HPV (Coley & Baker, 2013).

Exploratory Conclusion
While the hypothesized data did not yield significance at the bivariate level, other
independent variables did yield interesting results. At the univariate level, 74% of health
care providers had recommended the vaccine, 72% of respondents also had insurance to
cover vaccine, and 70% of respondents had very easy access to health care. At the
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bivariate level, all of these independent variables showed a significant association with
vaccine participation (p ≤0.05). Those who had insurance coverage were 4.6 times more
likely to be vaccinated than those who did not have coverage or were unaware if their
insurance companies covered the vaccine (95 % CI: (1.038-20.3810) (𝑋 2 = 4.353, 𝐷𝑓 =
1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.037). Those who found it vey easy to find a doctor, health care
provider, or clinic to access were 3.67 times more likely to get the vaccine, but these
results were not significant (95% CI: 0.862-15.593) (𝑋 2 = 3.265, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 =
0.071). Because this relationship was nearly significant, this variable was included in the
multivariate analysis. Participants whose doctor or healthcare provider recommended the
vaccine were 24 times more likely to be vaccinated than those not recommended (95%
CI: 3.675-156.738) (𝑋 2 = 14.727, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.0001). These three variables
that were found to be significantly associated at the bivariate level (p< 0.10) were
analyzed using forward stepwise linear regression. After the analysis was completed,
only being recommended to vaccination by a health care provider was a significant
predictor of vaccine participation (p<0.005) (Exploratory Tables and Figures: Table 2).
There is a 95% confidence that the general populations of people who are recommended
to get the vaccine are 3.675- 156.738 times more likely to do so. While this 95%
confidence is an accurate representation of the population, those receiving vaccination
based on recommendation, these values are not precise. This large range in the
confidence interval bounds could be due to the lack of respondents.
Limitations
A majority of the results found were limited to a lack of survey respondents. Only
60 respondents completed the survey, but only 43 of those 60 respondents were used.
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Low participation in this study could be due to a lack of incentives to complete the
survey, summer-break, or lack of access to technology. If there were incentives such as a
gift card, raffle, etc., parents could have been more likely to respond. However, if these
incentives had been in place, it could have jeopardized the confidentiality of the survey
by linking the survey to the respondents. Summer-break could have been a deterrent of
study participation. Students at Hattiesburg High School were out of school during the
release of the survey, thus parents/guardians could have been less inclined to participate
in a study that was not during the school year. Access to technology is another drawback
of study participation. Many parents/guardians may be older and not be technologically
savvy, or they could have not had access to the survey. All of these factors could have
contributed to a lack of survey participation. If the number of survey respondents was
increased, it is probable that the hypothesized and exploratory results would have
projected more significant findings.
Ostensibly, it is evident that parents/guardians are aware of the HPV vaccine and
are taking measures to protect their daughters against HPV. The hypothesized analysis
did not yield significance, but it did project a trend between income levels and
vaccination. Thus, allowing one to conclude that there is some correlation between SES
and HPV vaccination participation. The exploratory analysis did yield significant results
at both the bivariate and multivariate levels, thus showing that parents/guardians are more
likely to get their daughters vaccinated if there is very easy access, doctor
recommendations, and vaccine coverage.
Because the largest limitation of this study is lack of participation, the results can
only be discussed as preliminary findings. Further research efforts should focus on
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increasing participation among parents in order to assess if race and SES variables are
significantly associated with HPV vaccination participation. The only way to determine if
these outcome values interact significantly with each other is by increasing respondent
participation. Additional research to this preliminary analysis could answer the unknown
question as to whether or not minority caregivers in Mississippi from a low SES will be
less inclined to have their adolescent daughters vaccinated due to their lack of education
about the vaccine as well as their inability to afford the vaccine. Additional research
could also lead to HPV cost reform. Because HPV is one of the most preventive, yet
deadly STIs amongst women in the United States, further research is imperative.
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Appendix B:
Participant Permission Letter
Dear Prospective Participant,
My name is Kristen Dupard, and I am a student-researcher from the University of
Southern Mississippi. I am conducting an anonymous survey about parent’s/guardian’s
attitudes on accessibility and acceptability of HPV vaccination in adolescent females.
This study is important because it will begin to answer unknown questions of how
parents in Mississippi feel about HPV vaccination for their adolescent daughters; thus,
trying to develop policy guidelines for HPV education and vaccination. To participate in
this study, you must be 18 years or older and be the parent/ guardian of an adolescent
female that currently attends Hattiesburg High School. If you have more than one
adolescent daughter at Hattiesburg High School, please complete this survey for each
one. This survey is strictly voluntary and will remain completely anonymous. There are
no benefits or other incentives that will be provided to you or your adolescent daughter if
you choose to complete this survey. Some questions in this survey below are sensitive in
nature and may ask for personal information. Some risks for participating in this survey
include: asking about personal information regarding your adolescent daughter’s
vaccination information, your income information, your gender, and your race. All
participation in this study is voluntary, and has been approved by the Institutional Review
Board (IRB) at the University of Southern Mississippi. All data compiled from this
survey via the Qualtrics system will be destroyed once the data is collected and analyzed.
The survey will take 5-15 minutes to complete. Please answer all questions to
your comfort level. In addition, you may choose not to answer any questions that make
you uncomfortable. Remember, your participation in this survey is completely
anonymous. The results will be reported for the group of respondents as a whole, and no
individual names or specific individual information will be released. This study is
voluntary in nature, and you can choose whether or not to participate after reading this
information letter.
For more information regarding the survey or for any unforeseen circumstances
due to survey malfunction, uncomfortably, or any other inquires please contact the
following individual:
Dr. Ray G. Newman
Phone: 601-266-5435
Email: ray.newman@usm.edu.
Thank you for your consideration.
Sincerely,
Kristen Dupard
If you would like to begin the survey, select the ">>" tab in the bottom right hand corner
below.
If you choose not to continue, please exit out of this window.
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